Crossref
Doxorubicin-PLGA nanoparticles are immunomodulational antitumor therapeutics with dual cytotoxic and immune-stimulatory effects
Biopolymers and Cell · 24.04.2026 · 42 (1) · 54-67
DOI: 10.7124/bc.000b2e ↗Kurz gefasst
Fachartikel in der Zeitschrift Biopolymers and Cell, erschienen am 24.04.2026. Verfasst von M. D. Jaaffer und 1 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Jaaffer, M. D., & Chaloop, A. M. (2026). Doxorubicin-PLGA nanoparticles are immunomodulational antitumor therapeutics with dual cytotoxic and immune-stimulatory effects. Biopolymers and Cell, 42(1), 54-67. https://doi.org/10.7124/bc.000b2e
Vancouver
Jaaffer MD, Chaloop AM. Doxorubicin-PLGA nanoparticles are immunomodulational antitumor therapeutics with dual cytotoxic and immune-stimulatory effects. Biopolymers and Cell. 2026;42(1):54-67. doi:10.7124/bc.000b2e
BibTeX
@article{Jaaffer2026,
author = {Jaaffer, M. D. and Chaloop, A. M.},
title = {Doxorubicin-PLGA nanoparticles are immunomodulational antitumor therapeutics with dual cytotoxic and immune-stimulatory effects},
journal = {Biopolymers and Cell},
year = {2026},
volume = {42},
number = {1},
pages = {54--67},
doi = {10.7124/bc.000b2e}
}
EUVIMED